Wikidata

(Q62110903)

English

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

clinical trial

In more languages

Statements

title
UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy (English)
0 references
main subject
cancer
0 references
start time
August 1998
0 references
end time
August 2014
0 references
number of participants
668
0 references
research intervention
cisplatin
0 references
(RS)-cyclophosphamide
0 references
doxorubicin
0 references
Caelyx
0 references
etoposide
0 references
etoposide phosphate
0 references
cytarabine
0 references
vincristine
0 references
melphalan
0 references
thalidomide
0 references
carmustine
0 references
dexamethasone acetate
0 references
interferon-alpha
0 references
sargramostim
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110903&oldid=2035754060"